Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junction.
Odenthal M, Hee J, Gockel I, Sisic L, Schmitz J, Stoecklein NH, Driemel C, Möhlendick B, Schmidt T, Knoefel WT, Lang H, Büttner R, Ott K, Vallböhmer D. Odenthal M, et al. Among authors: mohlendick b. Int J Cancer. 2015 Jul 1;137(1):230-7. doi: 10.1002/ijc.29363. Epub 2014 Dec 3. Int J Cancer. 2015. PMID: 25429911 Free article.
Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer.
Hoffmann M, Pasch S, Schamberger T, Maneck M, Möhlendick B, Schumacher S, Brockhoff G, Knoefel WT, Izbicki J, Polzer B, Stoecklein NH, Klein CA. Hoffmann M, et al. Among authors: mohlendick b. Int J Cancer. 2018 Feb 15;142(4):833-843. doi: 10.1002/ijc.31108. Epub 2017 Nov 30. Int J Cancer. 2018. PMID: 29044505 Free article.
New model for gastroenteropancreatic large-cell neuroendocrine carcinoma: establishment of two clinically relevant cell lines.
Krieg A, Mersch S, Boeck I, Dizdar L, Weihe E, Hilal Z, Krausch M, Möhlendick B, Topp SA, Piekorz RP, Huckenbeck W, Stoecklein NH, Anlauf M, Knoefel WT. Krieg A, et al. Among authors: mohlendick b. PLoS One. 2014 Feb 14;9(2):e88713. doi: 10.1371/journal.pone.0088713. eCollection 2014. PLoS One. 2014. PMID: 24551139 Free PMC article.
NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis.
Radulovic I, Dogan B, Dohna-Schwake C, Schündeln MM, Siffert W, Möhlendick B. Radulovic I, et al. Among authors: mohlendick b. Pharmacogenet Genomics. 2021 Aug 1;31(6):140-143. doi: 10.1097/FPC.0000000000000432. Pharmacogenet Genomics. 2021. PMID: 33675325
The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19.
Schönfelder K, Breuckmann K, Elsner C, Dittmer U, Fistera D, Herbstreit F, Risse J, Schmidt K, Sutharsan S, Taube C, Jöckel KH, Siffert W, Kribben A, Möhlendick B. Schönfelder K, et al. Among authors: mohlendick b. Cytokine. 2021 Jun;142:155492. doi: 10.1016/j.cyto.2021.155492. Epub 2021 Mar 6. Cytokine. 2021. PMID: 33711707 Free PMC article. Clinical Trial.
Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study.
Schönfelder K, Breuckmann K, Elsner C, Dittmer U, Fistera D, Herbstreit F, Risse J, Schmidt K, Sutharsan S, Taube C, Jöckel KH, Siffert W, Kribben A, Möhlendick B. Schönfelder K, et al. Among authors: mohlendick b. Front Genet. 2021 Apr 21;12:667231. doi: 10.3389/fgene.2021.667231. eCollection 2021. Front Genet. 2021. PMID: 33968142 Free PMC article.
ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.
Möhlendick B, Schönfelder K, Breuckmann K, Elsner C, Babel N, Balfanz P, Dahl E, Dreher M, Fistera D, Herbstreit F, Hölzer B, Koch M, Kohnle M, Marx N, Risse J, Schmidt K, Skrzypczyk S, Sutharsan S, Taube C, Westhoff TH, Jöckel KH, Dittmer U, Siffert W, Kribben A. Möhlendick B, et al. Pharmacogenet Genomics. 2021 Oct 1;31(8):165-171. doi: 10.1097/FPC.0000000000000436. Pharmacogenet Genomics. 2021. PMID: 34001841 Free PMC article.
34 results